Navigation Links
Afid Therapeutics Obtains Positive Evaluation of its Triple Mode,Viral Sequestration Agents

LANSING, Mich., March 27, 2007 /PRNewswire/ -- Afid Therapeutics, Inc. announced that it received positive results on the ability of its new triple mode viral sequestration agents to block viral infections of mammalian cells. The audited results were obtained from a specialized, independent third party testing organization. The new viral sequestrating agents are designed to bind and inactivate viruses by 3 critical mechanisms thus blocking infection. They are aimed at viruses responsible for common causes of influenza in addition to SARS, bird flu and other avian influenzas. "Carbohydrate interactions are critical to the infection process in these systems. The technology capitalizes on the companies' rich carbohydrate chemistry technology portfolio and expertise," said Afid Founder and President Rawle Hollingsworth. Dr. Hollingsworth is a world authority on carbohydrate chemistry and holds nearly 50 issued US patents, scores of international patents and well over 100 publications on many aspects of carbohydrate chemistry critical to the success of the effort. The company intends to pursue both therapeutic and non- therapeutic applications. "The chemistry can be done easily enough that applications in public health, environmental, personal care and defense arenas are well within reach," adds Hollingsworth. "There are no real obstacles to scaling up," said Dr. Li Gao, Afid's research director.

Afid Therapeutics, Inc. was the first start-up firm to receive support from the "Rational Siting Push-Pull Accelerator" (RSPPA) grant to Michigan State University (MSU) from the Michigan Technology Tri-Corridor. The company recently received a $1.66M award from the Michigan 21st Century Jobs Creation Fund. It specializes in advanced chemistry based on carbohydrates with a focus on the drug discovery and development areas and provides advanced chemical intermediates to over 50 pharmaceutical clients around the world.<
'"/>




Page: 1 2

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care

Post Your Comments:
(Date:12/3/2009)... 3 Stryker Corporation (...rectors has authorized the Company to repurchase u..., timing and amount of any purchases will be deter...valuation of market conditions, stock price and ot...iderations. Purchases may be made from time to ti...
(Date:12/3/2009)...ec. 3, 2009 Raytheon BBN Technolog... (NYSE: RTN ), has licensed its patented, award-...y to FUJIFILM Corp. ,, FUJIFILM intends to int...system. Combined with SDM technology, the Aspire H...mages for 3-D viewing. FUJIFILM will display the R...
(Date:12/3/2009)...3 New state investments...y build a new cold storage facility and help a Phi...ions while creating at least 20 jobs, Governor Edw...ania Industrial Development Authority yesterday ap...The investments, in the form of low-interest loans...
Breaking Medicine Technology:Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 2Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation 3Governor Rendell: New State Investments Bear Fruit in Adams County; Help Pharmaceutical Company Expand in Philadelphia 2Stemedica Completes Meeting with the FDA 14477 1Stemedica Completes Meeting with the FDA 14477 2Stemedica Completes Meeting with the FDA 14477 3deVere and Partners Raises Funds for Geneva Children in Need 59509 1deVere and Partners Raises Funds for Geneva Children in Need 59509 2deVere and Partners Raises Funds for Geneva Children in Need 59509 3New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 1New ALS Patient Simulator Advanced Provides Valuable Training for EMS Teams and In Hospital Emergency Personnel 5499 2
...ase 3 Once Weekly Investigational Diabetes Therapy...tching from Exenatide Taken Twice a Day, SAN FRAN...: AMLN ), Eli Lilly and Company (NYSE: LLY ), an...results from a 52-week open-label clinical,study t...weekly, a,long-acting release formulation of exena...
...itial Trial Results Expected in Q3 2008, Conferen... p.m. Eastern Tim...uticals, Inc. (Nasdaq: ALXA ) announced today tha... clinical trial with AZ-004 (Staccato(R),loxapine)...developed for,the treatment of acute agitation in ...
Other Medicine Technology:After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 2After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 3After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 4After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 5After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 6After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 7After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 8After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008 9Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 2Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 3Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 4Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 5Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 6Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation 7
(Date:12/3/2009)...ritis Foundation bestowed its highest nationwide h...ational meeting in Atlanta. , ...ndation bestowed its highest nationwide honors to ...eeting on Nov. 20 in Atlanta. The honorees are as...guished Service ,The Arthritis Foundation honored ...
(Date:12/3/2009)...and easy way to keep a notebook of surgical cases ...nd one touch exporting keeps track of and reviewin... medical provider. , (PRW...application for surgery, can be used by surgeons, ... PA’s. Just about anyone in a surgical sett...
(Date:12/3/2009)...style Advisors at Virtual Spa, mySpaShop.com have ...nding that perfect gift this holiday season. They ...itness and wellness that can be personalized for e... (PRWEB) December 3, 2009 ...ered an assortment of holiday gifts from a variety...
(Date:12/3/2009)...Scott RN, hopes to cheer up children during the ho...ks, “Little Big Wolf,” and “Grin...ill go to children’s hospitals nationwide. ...9 -- Carlton Scott RN , hopes to bring holiday ch... and self-illustrated picture books. Having alread...
(Date:12/3/2009)...tionary device that allows people to sanitize thei... (PRWEB) December 3, 2009 -- ...d magazine covers day after day -- dire statistics...fluenza A (swine flu) . Reports of vaccine shorta...g picture during this pandemic. , ,But finally, t...
Breaking Medicine News(10 mins):Health News:Arthritis Foundation Bestows Highest National Awards 2Health News:Arthritis Foundation Bestows Highest National Awards 3Health News:Arthritis Foundation Bestows Highest National Awards 4Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 2Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 3Health News:Bring Spa Home for the Holidays at mySpaShop & Celebrate Recipes for Personal Spa Treatments 4Health News:Traveling Nurse Cheers up Kids with Handmade Books 2Health News:Traveling Nurse Cheers up Kids with Handmade Books 3Health News:Finally, Some Good News about Swine Flu 2
...s of America,s 100,000,emergency nurses in serving...and improve the nation,s health is the central foc...l be celebrated October 7-13. "Stepping into thei...ten serve as the first line in patient care in,eme...
...h plans are expecting premium,rate increases in 20...year,s expectation of 8.2%. This is the fourth con...herlock Company conducted this survey in September...t the East South Central region is,expected to hav...
...hritis and Injury Sufferers to All-Natural Pain ...OVE, Utah, Oct. 9 All pain creams are not,created... cream and heavy,doses of menthol and salicylates ...m ), have created a Flash virtual tour of how,thei...
...n recognition of,National School Lunch Week, Octob..., is challenging schools and families to transform... appetizing meals that teach students,about good f...s family-friendly,recipes and recipes that can be ...
...s Outstanding Service, LAKESIDE, Calif., Oct. 9 ...P, the nonprofit membership,organization for peopl...ndrus Award for Community Service, the Association...ference in the lives of,others., AARP California ...
...sophageal manometry are the gold standards of meth...isorders, respectively. Intraluminal refluxate can...osis is made by backward movement of gastric conte...or manometric pathology was found in 71.1% of the ...
Other Medicine News:Health News:Vital Work of Emergency Nurses Honored Across the Nation During Emergency Nurses Week, October 7-13, 2007 2Health News:MyoMed Launches Flash Virtual Tour of Toxin-Free Pain Relief 2Health News:Lunch Lady Challenges Schools, Families to Make Kids' Nutrition a Priority 2Health News:Lakeside Resident Wins AARP Community Service Award 2
Lacrimal Cannula, 19 g / 23 g. Curved
Anterior Chamber Needle, 27 g. Angled
Anterior Chamber Needle, 20 g. Angled
Retinal Hydrodissection Cannula 41 Gauge I.D.
Medicine Products: